https://novapharmanews.com/us/news/fda-salmonella-moringa-leaf-powder-recall-january-2026 2026-06-10T11:04:10.961Z NovaPharmaNews en 2026-06-09T08:05:43.896Z FDA investigates Salmonella in moringa leaf powder, expands recall Salmonella https://novapharmanews.com/uploads/articles/fda-salmonella-moringa-leaf-powder-recall-january-2026.webp FDA investigates Salmonella in moringa leaf powder, expands recall https://novapharmanews.com/eu/news/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026 2026-06-10T11:04:18.969Z NovaPharmaNews en 2026-06-09T02:30:45.616Z KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026) ISENTRESS, raltegravir, Apretude, Biktarvy https://novapharmanews.com/uploads/articles/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026.webp KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026) https://novapharmanews.com/us/news/nektar-therapeutics-pipeline-update-rezpeg-amphotericin-b-uk-site-changes 2026-06-10T16:26:00.445Z NovaPharmaNews en 2026-06-08T22:57:12.804Z Nektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes REZPEG, amphotericin B https://novapharmanews.com/uploads/articles/nektar-therapeutics-pipeline-update-rezpeg-amphotericin-b-uk-site-changes.webp Nektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes https://novapharmanews.com/us/news/vanda-tradipitant-update-fda-re-review-dec-5-2025 2026-06-10T20:00:36.602Z NovaPharmaNews en 2026-06-08T22:57:00.230Z Vanda tradipitant update: FDA re-review extends to Dec. 5, 2025 Tradipitant https://novapharmanews.com/uploads/articles/vanda-tradipitant-update-fda-re-review-dec-5-2025.webp Vanda tradipitant update: FDA re-review extends to Dec. 5, 2025 https://novapharmanews.com/us/news/sanofi-pipeline-pdf-dupixent-lantus-2026-catalysts 2026-06-10T11:08:35.268Z NovaPharmaNews en 2026-06-08T22:56:13.878Z Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts Dupixent, Lantus https://novapharmanews.com/uploads/articles/sanofi-pipeline-pdf-dupixent-lantus-2026-catalysts.webp Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts https://novapharmanews.com/us/news/cardiff-oncology-pipeline-update-onvansertib-trials-fda-meeting-catalysts 2026-06-10T11:08:21.657Z NovaPharmaNews en 2026-06-08T22:56:09.565Z Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts onvansertib, oncology, cancers https://novapharmanews.com/uploads/articles/cardiff-oncology-pipeline-update-onvansertib-trials-fda-meeting-catalysts.webp Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts https://novapharmanews.com/us/news/alnylam-pipeline-update-amvuttra-catalysts-outlook-profitability 2026-06-10T20:08:57.162Z NovaPharmaNews en 2026-06-08T22:56:07.139Z Alnylam pipeline update: AMVUTTRA catalysts, outlook and profitability AMVUTTRA, ATTR-CM, TTR Amyloid https://novapharmanews.com/uploads/articles/alnylam-pipeline-update-amvuttra-catalysts-outlook-profitability.webp Alnylam pipeline update: AMVUTTRA catalysts, outlook and profitability https://novapharmanews.com/us/news/neurocrine-biosciences-pipeline-update-catalyst-watch 2026-06-10T15:31:40.893Z NovaPharmaNews en 2026-06-08T22:56:06.953Z Neurocrine Biosciences pipeline update: what analysts should watch next elagolix, neurology, endocrinology, psychiatry, immunology, women's health https://novapharmanews.com/uploads/articles/neurocrine-biosciences-pipeline-update-catalyst-watch.webp Neurocrine Biosciences pipeline update: what analysts should watch next https://novapharmanews.com/us/news/arcus-biosciences-pipeline-catalyst-update-casdatifan-quemliclustat-domvanalimab 2026-06-10T17:32:39.853Z NovaPharmaNews en 2026-06-08T22:55:43.634Z Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab casdatifan, quemliclustat, domvanalimab, kidney cancer, ccRCC, pancreatic cancer, lung cancer https://novapharmanews.com/uploads/articles/arcus-biosciences-pipeline-catalyst-update-casdatifan-quemliclustat-domvanalimab.webp Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab https://novapharmanews.com/us/news/syndax-pipeline-update-revuforj-niktimvo-catalysts 2026-06-10T11:04:04.462Z NovaPharmaNews en 2026-06-08T22:51:15.097Z Syndax pipeline update: Revuforj and Niktimvo catalysts to watch revumenib, axatilimab, Revuforj, Niktimvo https://novapharmanews.com/uploads/articles/syndax-pipeline-update-revuforj-niktimvo-catalysts.webp Syndax pipeline update: Revuforj and Niktimvo catalysts to watch https://novapharmanews.com/us/news/tillomed-laboratories-pipeline-catalyst-update 2026-06-10T11:08:36.670Z NovaPharmaNews en 2026-06-08T22:50:21.790Z Tillomed Laboratories update: pipeline, melphalan and next catalysts melphalan, oncology, analgesia, cardio-vascular, women's health, anti-infectives, anti-epileptics, gastro-intestinal, genito-urinary, immunosuppressants https://novapharmanews.com/uploads/articles/tillomed-laboratories-pipeline-catalyst-update.webp Tillomed Laboratories update: pipeline, melphalan and next catalysts